Terminated PHASE4 INTERVENTIONAL 2-arm NCT01530880

Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage

Sponsor: Columbia University

Conditions Fever

Interventions Acetaminophen (Standard of Care) Intravenous Ibuprofen

Updated 9 times since 2017 Last updated: Aug 15, 2017 Started: Oct 31, 2012 Primary completion: Mar 17, 2016 Completion: Mar 17, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

PI no longer at institution

Other terminated trials from Columbia University

See all terminations from Columbia University

Other Fever trials with similar outcome

Browse all Fever trials

A PHASE4 clinical study on Fever, this trial is terminated or withdrawn. The trial is conducted by Columbia University and has accumulated 9 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2023 — Jul 2024 [monthly]

Terminated PHASE4
Dec 2022 — Jan 2023 [monthly]

Terminated PHASE4
Jan 2021 — Dec 2022 [monthly]

Terminated PHASE4

▶ Show 4 earlier versions

Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Sep 2017 — Jun 2018 [monthly]

Terminated PHASE4

Status: Unknown Status → Terminated
Feb 2017 — Sep 2017 [monthly]

Unknown Status PHASE4
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE4

First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Columbia University
Cumberland Pharmaceuticals

Data source: Columbia University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States